Skip to main content

What the FDA labels say about taking them together

Cabozantinib and ketoconazole

Cabozantinib's FDA label (Cometriq) of October 18, 2025 names ketoconazole in its drug interactions section; the ketoconazole label PlainMeds reads does not name cabozantinib. The cabozantinib label: “Administration of a strong CYP3A4 inhibitor, ketoconazole to healthy subjects increased single-dose plasma cabozantinib exposure by 38%.”

Check it at the source: the cabozantinib FDA label on DailyMed (effective October 19, 2025, Exelixis, Inc.); the ketoconazole FDA label on DailyMed (effective January 28, 2026, E. Fougera & Co. a division of Fougera Pharmaceuticals, LLC).

What does the cabozantinib label say about ketoconazole?

Cometriq label (Exelixis, Inc., October 18, 2025), drug interactions

Administration of a strong CYP3A4 inhibitor, ketoconazole to healthy subjects increased single-dose plasma cabozantinib exposure by 38%.

Source: FDA drug label (Cometriq, NDA203756), Exelixis, Inc., effective October 18, 2025 (SPL set 1a0c3bea-c87b-4d25-bb44-5f0174da6b34), via openFDA

Source: FDA drug label (CABOMETYX), Exelixis, Inc., effective October 19, 2025 (SPL set 3850cce2-6137-42e5-a792-d318c4a4b3b5), via openFDA; the full label on DailyMed

What does the ketoconazole label say about cabozantinib?

Ketoconazole's label (effective January 28, 2026) does not name cabozantinib in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (ketoconazole), E. Fougera & Co. a division of Fougera Pharmaceuticals, LLC, effective January 28, 2026 (SPL set cad7c647-34a9-4e4e-83b3-8d78e58f588f), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

0Cabozantinib generic labelers
30Ketoconazole generic labelers
CabozantinibKetoconazole
Labeled forn/aFungal infections
Boxed warningNoNo
Pharmacy cost (NADAC)n/a$0.249 per gram 2% cream
Shortage nowNo current entryNo current entry

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?